Top Markets
Coin of the day
Mizuho Medy Co.,Ltd. Mizuho Medy Co.,Ltd.

Mizuho Medy Co.,Ltd.

4595
Rang in aandelen #18063
Established in 1977 and headquartered in Tosu, Japan, Mizuho Medy Co.,Ltd.... Established in 1977 and headquartered in Tosu, Japan, Mizuho Medy Co.,Ltd. specializes in the research, development, production, and distribution of in-vitro diagnostic solutions, complemented by scientific and technical information services. While its primary operations are in Japan, the company maintains an international presence through import and export activities, extending its reach to countries including the United States, Belgium, Finland, the Netherlands, Taiwan, and Thailand. Its extensive product lineup includes a wide array of immunoassay test kits designed for detecting pathogens such as influenza viruses, RS virus, human metapneumovirus, Streptococcus pneumoniae, Legionella, Mycoplasma pneumoniae, adenovirus, rotavirus, norovirus, and Group A streptococcus. Additionally, Mizuho Medy offers kits for pregnancy, ovulation, and fecal occult blood screening. The company also provides advanced tools like gene analysis instruments and specialized diagnostic kits for SARS-CoV-2 detection and Mycoplasma pneumoniae nucleic acid analysis.
Aandeelprijs
$11.23
Marktkapitalisatie
$214.01M
Verandering (1 dag)
-0.06%
Verandering (1 jaar)
5.75%
Land
JP
Handel Mizuho Medy Co.,Ltd. (4595)

Categorie

P/B-ratio voor Mizuho Medy Co.,Ltd. (4595)
P/B-ratio op 2026 TTM: 0
Volgens de meest recente financiële rapporten en aandelenkoers van Mizuho Medy Co.,Ltd. is de huidige P/B-ratio (TTM) 0. Eind 2026 had het bedrijf een P/B-ratio van 0.
P/B-ratiohistoriek voor Mizuho Medy Co.,Ltd. van 2026 tot 2026
P/B-ratio aan het einde van elk jaar
Jaar P/B-ratio Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
P/B-ratio voor vergelijkbare bedrijven of concurrenten